Retinal Cell Map Could Advance Therapies for Blinding Diseases
An NIH discovery is shedding light on tissue targeted by age-related macular degeneration and other eye diseases. Researchers have identified distinct differences among the cells comprising a tissue in the retina that is vital to human visual perception.
Hypertension During Pregnancy Linked to Future Cardiac Events
An NIH-funded study explains factors related to increased risk for heart attack or stroke among women who had hypertension, or high blood pressure, while pregnant.
NIH Starts Clinical Trial of Epstein-Barr Vaccine
NIAID launched an early-stage clinical trial to evaluate an investigational preventative vaccine for Epstein-Barr virus (EBV).
Vision Improves with Treatment for Blinding Blood Vessel Condition
New research shows that a treatment for retinal vein occlusion (RVO) yields long-lasting vision gains, with visual acuity remaining significantly above baseline at 5 years. However, many patients require ongoing treatment.
Researchers Create 3-D Model for Rare Neuromuscular Disorders
A scientific team supported by NIH has created a tiny, bioengineered 3-D model that mimics the biology of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy, a pair of rare, devastating neuromuscular diseases.
Tobacco Rates are Decreasing Among Adults with Depression, Substance Use Disorder
A new analysis of national survey data reveals significant reductions in cigarette use among U.S. adults with major depression, substance use disorder or both from 2006 to 2019.
Blocking Hormone Reduces Alzheimer’s Symptoms in Mice
Women have a higher risk than men for developing Alzheimer’s disease and experience a broader range of cognitive symptoms—those related to thinking, learning and memory.
Peripheral Vision Study Yields Clues About Brain Systems for Attention
Minuscule involuntary eye movements, known as microsaccades, can occur even while staring at a fixed point in space.
Medication Helps Protect Insulin Production in Type 1 Diabetes
A drug approved to treat high blood pressure, called verapamil, was found protective in people with type 1 diabetes.